Akari Therapeutics (AKTX) Enterprise Value Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.77% |
| Dec 31, 2025 | -95.68% |
| Sep 30, 2025 | 92.76% |
| Jun 30, 2025 | 35.10% |
| Mar 31, 2025 | -97.10% |
| Dec 31, 2024 | 32.41% |
| Jun 30, 2024 | 68.48% |
| Dec 31, 2023 | 70.98% |
| Jun 30, 2023 | -62.55% |
| Dec 31, 2022 | -142,082.64% |
| Jun 30, 2022 | 42.01% |
| Mar 31, 2022 | -150.78% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | -8.71% |
| Jun 30, 2021 | -10.27% |
| Mar 31, 2021 | 14.75% |
| Dec 31, 2020 | -99,900.00% |
| Sep 30, 2020 | -106.40% |
| Jun 30, 2020 | -362.82% |
| Mar 31, 2020 | -27.90% |
| Dec 31, 2019 | 11.18% |
| Sep 30, 2019 | 43.67% |
| Jun 30, 2019 | 82.34% |
| Mar 31, 2019 | 74.44% |
| Dec 31, 2018 | 77.22% |
| Sep 30, 2018 | 49.83% |
| Jun 30, 2018 | 54.28% |
| Mar 31, 2018 | 45.78% |
| Dec 31, 2017 | 36.00% |
| Sep 30, 2017 | 81.48% |
| Jun 30, 2017 | 70.36% |
| Mar 31, 2017 | 28.18% |
| Dec 31, 2016 | 35.96% |
| Sep 30, 2016 | -3,326.67% |
| Jun 30, 2016 | -3,357.29% |
| Mar 31, 2016 | -4,523.41% |
| Dec 31, 2015 | -1,971.24% |
| Sep 30, 2015 | -6,224.30% |
| Jun 30, 2015 | 70.70% |
| Mar 31, 2015 | 90.39% |
| Dec 31, 2014 | -501.00% |
| Dec 31, 2013 | 49.85% |
| Dec 31, 2012 | -18,300.00% |